Cameron-Burr Keaton T, Bola R Aaron, Kiyatkin Eugene A
Behavioral Neuroscience Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, DHHS, 251 Bayview Blvd, Baltimore, MD, 21224, USA.
Psychopharmacology (Berl). 2023 Apr;240(4):785-795. doi: 10.1007/s00213-023-06321-x. Epub 2023 Jan 26.
Hyperthermia induced by psychomotor stimulants may cause leakage of the blood-brain barrier, vasogenic edema, and lethality in extreme cases. Current treatments such as whole-body cooling are only symptomatic and a clear need to develop pharmacological interventions exists. Dantrolene sodium, a peripheral muscle relaxant used in the treatment of malignant hyperthermia, has been proposed as potentially effective to treat MDMA-hyperthermia in emergency rooms. However, debate around its efficacy for this indication persists.
To investigate dantrolene as a treatment for illicit hyperthermia induced by psychomotor stimulant drugs, we examined how Ryanodex®, a concentrated formulation of dantrolene sodium produced by Eagle Pharmaceuticals, influences 3,4-methylenedioxymethamphetamine (MDMA)- and methamphetamine (METH)-induced hyperthermia in awake freely moving rats. We injected rats with moderate doses of MDMA (9 mg/kg) and METH (9 mg/kg) and administered Ryanodex® intravenously (6 mg/kg) after the development of robust hyperthermia (>2.5 °C) mimicking clinical acute intoxication. We conducted simultaneous temperature recordings in the brain, temporal muscle, and skin to determine the basic mechanisms underlying temperature responses. To assess the efficacy of dantrolene in attenuating severe hyperthermia, we administered MDMA to rats maintained in a warm ambient environment (29 °C), conditions which produce robust brain and body hyperthermia (>40 °C) and lethality.
Dantrolene failed to attenuate MDMA- and METH-induced hyperthermia, though locomotor activity was significantly reduced. All animals maintained at warm ambient temperatures that received dantrolene during severe drug-induced hyperthermia died within or soon after the recording session.
Our results suggest that dantrolene sodium formulations are not mechanistically suited to treat MDMA- and METH-induced hyperthermia.
精神运动性兴奋剂引起的体温过高可能导致血脑屏障渗漏、血管源性水肿,在极端情况下甚至会导致死亡。目前的全身降温等治疗方法只是对症治疗,因此迫切需要开发药物干预措施。丹曲林钠是一种用于治疗恶性高热的外周肌肉松弛剂,有人提出它在急诊室治疗摇头丸引起的体温过高方面可能有效。然而,围绕其在该适应症上的疗效仍存在争议。
为了研究丹曲林作为治疗精神运动性兴奋剂药物引起的非法体温过高的方法,我们研究了Eagle制药公司生产的丹曲林钠浓缩制剂Ryanodex®如何影响清醒自由活动大鼠中3,4-亚甲基二氧甲基苯丙胺(摇头丸)和甲基苯丙胺(冰毒)引起的体温过高。我们给大鼠注射中等剂量的摇头丸(9毫克/千克)和冰毒(9毫克/千克),并在出现模拟临床急性中毒的强烈体温过高(>2.5°C)后静脉注射Ryanodex®(6毫克/千克)。我们同时记录大脑、颞肌和皮肤的温度,以确定温度反应的基本机制。为了评估丹曲林在减轻严重体温过高方面的疗效,我们给处于温暖环境(29°C)中的大鼠注射摇头丸,这种环境会导致强烈的脑和身体体温过高(>40°C)并导致死亡。
丹曲林未能减轻摇头丸和冰毒引起的体温过高,尽管运动活动显著减少。在严重药物引起的体温过高期间接受丹曲林治疗的所有处于温暖环境温度下的动物在记录期内或记录期后不久死亡。
我们的结果表明,丹曲林钠制剂在机制上不适合治疗摇头丸和冰毒引起的体温过高。